150 related articles for article (PubMed ID: 1640364)
1. Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction.
Gariépy L; Fenyves D; Villeneuve JP
J Pharm Sci; 1992 Mar; 81(3):255-8. PubMed ID: 1640364
[TBL] [Abstract][Full Text] [Related]
2. Propranolol metabolism by isolated hepatocytes from normal and cirrhotic rat livers: the effect of albumin.
Gariepy L; Fenyves D; Petit JL; Raymond G; Villeneuve JP
Can J Physiol Pharmacol; 1990 Jun; 68(6):657-62. PubMed ID: 2164869
[TBL] [Abstract][Full Text] [Related]
3. A carrier-protein receptor is not a prerequisite for avid hepatic elimination of highly bound compounds: a study of propranolol elimination by the isolated perfused rat liver.
Jones DB; Ching MS; Smallwood RA; Morgan DJ
Hepatology; 1985; 5(4):590-3. PubMed ID: 2991106
[TBL] [Abstract][Full Text] [Related]
4. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
[TBL] [Abstract][Full Text] [Related]
5. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
[TBL] [Abstract][Full Text] [Related]
6. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
[TBL] [Abstract][Full Text] [Related]
7. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
Terao N; Shen DD
J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination.
Miyauchi S; Sawada Y; Iga T; Hanano M; Sugiyama Y
Biol Pharm Bull; 1993 Oct; 16(10):1019-24. PubMed ID: 8287031
[TBL] [Abstract][Full Text] [Related]
9. Disposition kinetics of propranolol isomers in the perfused rat liver.
Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
[TBL] [Abstract][Full Text] [Related]
10. Effect of age on the hepatic clearance of propranolol in rats.
Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
[TBL] [Abstract][Full Text] [Related]
12. Protein binding and hepatic clearance: studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation.
Schary WL; Rowland M
J Pharmacokinet Biopharm; 1983 Jun; 11(3):225-43. PubMed ID: 6644551
[TBL] [Abstract][Full Text] [Related]
13. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
Fenyves D; Gariépy L; Villeneuve JP
Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
[TBL] [Abstract][Full Text] [Related]
14. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A
Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248
[TBL] [Abstract][Full Text] [Related]
15. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
Chindavijak B; Belpaire FM; Bogaert MG
J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.
Keyler DE; Pentel PR
Biochem Pharmacol; 1989 Apr; 38(7):1163-8. PubMed ID: 2539818
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
[TBL] [Abstract][Full Text] [Related]
18. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
[TBL] [Abstract][Full Text] [Related]
19. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of hypoxia on the disposition of propranolol and sodium taurocholate by the isolated perfused rat liver.
Jones DB; Mihaly GW; Smallwood RA; Webster LK; Morgan DJ; Madsen NP
Hepatology; 1984; 4(3):461-6. PubMed ID: 6724514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
